[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamic acid;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]cyclopentanecarboxamide;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]-2-cyclopropylacetamide;ethyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate;methyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate

C102H80Cl5N25O13 — CID 159991999

IUPAC[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamic acid;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]cyclopentanecarboxamide;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]-2-cyclopropylacetamide;ethyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate;methyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate
SMILESCCOC(=O)Nc1nc(-c2ccccc2)c(-c2cc(Cl)c3[nH]ncc3c2)[nH]c1=O.COC(=O)Nc1nc(-c2ccccc2)c(-c2cc(Cl)c3[nH]ncc3c2)[nH]c1=O.O=C(CC1CC1)Nc1nc(-c2ccccc2)c(-c2cc(Cl)c3[nH]ncc3c2)[nH]c1=O.O=C(Nc1nc(-c2ccccc2)c(-c2cc(Cl)c3[nH]ncc3c2)[nH]c1=O)C1CCCC1.O=C(O)Nc1nc(-c2ccccc2)c(-c2cc(Cl)c3[nH]ncc3c2)[nH]c1=O
InChIInChI=1S/C23H20ClN5O2.C22H18ClN5O2.C20H16ClN5O3.C19H14ClN5O3.C18H12ClN5O3/c24-17-11-15(10-16-12-25-29-18(16)17)20-19(13-6-2-1-3-7-13)26-21(23(31)27-20)28-22(30)14-8-4-5-9-14;23-16-10-14(9-15-11-24-28-18(15)16)20-19(13-4-2-1-3-5-13)26-21(22(30)27-20)25-17(29)8-12-6-7-12;1-2-29-20(28)25-18-19(27)24-17(16(23-18)11-6-4-3-5-7-11)12-8-13-10-22-26-15(13)14(21)9-12;1-28-19(27)24-17-18(26)23-16(15(22-17)10-5-3-2-4-6-10)11-7-12-9-21-25-14(12)13(20)8-11;19-12-7-10(6-11-8-20-24-13(11)12)15-14(9-4-2-1-3-5-9)21-16(17(25)22-15)23-18(26)27/h1-3,6-7,10-12,14H,4-5,8-9H2,(H,25,29)(H,27,31)(H,26,28,30);1-5,9-12H,6-8H2,(H,24,28)(H,27,30)(H,25,26,29);3-10H,2H2,1H3,(H,22,26)(H,24,27)(H,23,25,28);2-9H,1H3,(H,21,25)(H,23,26)(H,22,24,27);1-8H,(H,20,24)(H,21,23)(H,22,25)(H,26,27)
InChIKeyOHBJRNOEPXPNSO-UHFFFAOYSA-N
MW2041.19 g/mol
LogP20.87
Rot. Bonds19

About [6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamic acid;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]cyclopentanecarboxamide;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]-2-cyclopropylacetamide;ethyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate;methyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate

[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamic acid;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]cyclopentanecarboxamide;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]-2-cyclopropylacetamide;ethyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate;methyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate (PubChem CID 159991999) has the molecular formula C102H80Cl5N25O13 and a molecular weight of 2041.19 g/mol. Its IUPAC name is [6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamic acid;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]cyclopentanecarboxamide;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]-2-cyclopropylacetamide;ethyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate;methyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate.

Molecular Properties

Compound Name[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamic acid;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]cyclopentanecarboxamide;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]-2-cyclopropylacetamide;ethyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate;methyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate
PubChem CID159991999
Molecular FormulaC102H80Cl5N25O13
Molecular Weight2041.19 g/mol
Exact Mass2037.48
IUPAC Name[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamic acid;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]cyclopentanecarboxamide;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]-2-cyclopropylacetamide;ethyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate;methyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate
SMILESCCOC(=O)Nc1nc(-c2ccccc2)c(-c2cc(Cl)c3[nH]ncc3c2)[nH]c1=O.COC(=O)Nc1nc(-c2ccccc2)c(-c2cc(Cl)c3[nH]ncc3c2)[nH]c1=O.O=C(CC1CC1)Nc1nc(-c2ccccc2)c(-c2cc(Cl)c3[nH]ncc3c2)[nH]c1=O.O=C(Nc1nc(-c2ccccc2)c(-c2cc(Cl)c3[nH]ncc3c2)[nH]c1=O)C1CCCC1.O=C(O)Nc1nc(-c2ccccc2)c(-c2cc(Cl)c3[nH]ncc3c2)[nH]c1=O
InChIInChI=1S/C23H20ClN5O2.C22H18ClN5O2.C20H16ClN5O3.C19H14ClN5O3.C18H12ClN5O3/c24-17-11-15(10-16-12-25-29-18(16)17)20-19(13-6-2-1-3-7-13)26-21(23(31)27-20)28-22(30)14-8-4-5-9-14;23-16-10-14(9-15-11-24-28-18(15)16)20-19(13-4-2-1-3-5-13)26-21(22(30)27-20)25-17(29)8-12-6-7-12;1-2-29-20(28)25-18-19(27)24-17(16(23-18)11-6-4-3-5-7-11)12-8-13-10-22-26-15(13)14(21)9-12;1-28-19(27)24-17-18(26)23-16(15(22-17)10-5-3-2-4-6-10)11-7-12-9-21-25-14(12)13(20)8-11;19-12-7-10(6-11-8-20-24-13(11)12)15-14(9-4-2-1-3-5-9)21-16(17(25)22-15)23-18(26)27/h1-3,6-7,10-12,14H,4-5,8-9H2,(H,25,29)(H,27,31)(H,26,28,30);1-5,9-12H,6-8H2,(H,24,28)(H,27,30)(H,25,26,29);3-10H,2H2,1H3,(H,22,26)(H,24,27)(H,23,25,28);2-9H,1H3,(H,21,25)(H,23,26)(H,22,24,27);1-8H,(H,20,24)(H,21,23)(H,22,25)(H,26,27)
InChIKeyOHBJRNOEPXPNSO-UHFFFAOYSA-N
XLogP20.87
TPSA556.34 Ų
H-Bond Donors16
H-Bond Acceptors22
Rotatable Bonds19
Heavy Atoms145
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002041.19
LogP ≤ 520.87
H-Bond Donors ≤ 516
H-Bond Acceptors ≤ 1022

Analyze [6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamic acid;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]cyclopentanecarboxamide;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]-2-cyclopropylacetamide;ethyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate;methyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-(but-2-ynylamino)-6-(7-chloro-1H-indazol-5-yl)-5-phenyl-1H-pyrazin-2-one;6-(7-chloro-1H-indazol-5-yl)-3-[(1-methylpiperidin-4-yl)amino]-5-phenyl-1H-pyrazin-2-one;6-(7-chloro-1H-indazol-5-yl)-3-[(1-methylpyrrolidin-3-yl)amino]-5-phenyl-1H-pyrazin-2-one;6-(7-chloro-1H-indazol-5-yl)-5-phenyl-3-(prop-2-enylamino)-1H-pyrazin-2-one;6-(7-chloro-1H-indazol-5-yl)-5-phenyl-3-(prop-2-ynylamino)-1H-pyrazin-2-one
CID 157214438
tert-butyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate;cyclopentyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate;cyclopropyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate;(1-methylpiperidin-4-yl)methyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate;propan-2-yl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate
CID 158215035
1-benzyl-3-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]urea;1-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]-3-cyclobutylurea;1-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]-3-(cyclopentylmethyl)urea;1-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]-3-[(1-methylazetidin-3-yl)methyl]urea;1-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]-3-(1-methylpiperidin-4-yl)urea
CID 159291829
1-tert-butyl-3-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]urea;1-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]-3-cyclopropylurea;1-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]-3-ethylurea;1-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]-3-propan-2-ylurea;[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]urea
CID 159904881

Frequently Asked Questions

What is the IUPAC name of [6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamic acid;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]cyclopentanecarboxamide;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]-2-cyclopropylacetamide;ethyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate;methyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate?
The IUPAC name of [6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamic acid;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]cyclopentanecarboxamide;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]-2-cyclopropylacetamide;ethyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate;methyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate (CID 159991999) is [6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamic acid;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]cyclopentanecarboxamide;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]-2-cyclopropylacetamide;ethyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate;methyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate.
What is the SMILES notation for [6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamic acid;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]cyclopentanecarboxamide;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]-2-cyclopropylacetamide;ethyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate;methyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate?
The canonical SMILES for [6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamic acid;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]cyclopentanecarboxamide;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]-2-cyclopropylacetamide;ethyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate;methyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate is CCOC(=O)Nc1nc(-c2ccccc2)c(-c2cc(Cl)c3[nH]ncc3c2)[nH]c1=O.COC(=O)Nc1nc(-c2ccccc2)c(-c2cc(Cl)c3[nH]ncc3c2)[nH]c1=O.O=C(CC1CC1)Nc1nc(-c2ccccc2)c(-c2cc(Cl)c3[nH]ncc3c2)[nH]c1=O.O=C(Nc1nc(-c2ccccc2)c(-c2cc(Cl)c3[nH]ncc3c2)[nH]c1=O)C1CCCC1.O=C(O)Nc1nc(-c2ccccc2)c(-c2cc(Cl)c3[nH]ncc3c2)[nH]c1=O.
What is the InChIKey of [6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamic acid;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]cyclopentanecarboxamide;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]-2-cyclopropylacetamide;ethyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate;methyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate?
The InChIKey is OHBJRNOEPXPNSO-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H20ClN5O2.C22H18ClN5O2.C20H16ClN5O3.C19H14ClN5O3.C18H12ClN5O3/c24-17-11-15(10-16-12-25-29-18(16)17)20-19(13-6-2-1-3-7-13)26-21(23(31)27-20)28-22(30)14-8-4-5-9-14;23-16-10-14(9-15-11-24-28-18(15)16)20-19(13-4-2-1-3-5-13)26-21(22(30)27-20)25-17(29)8-12-6-7-12;1-2-29-20(28)25-18-19(27)24-17(16(23-18)11-6-4-3-5-7-11)12-8-13-10-22-26-15(13)14(21)9-12;1-28-19(27)24-17-18(26)23-16(15(22-17)10-5-3-2-4-6-10)11-7-12-9-21-25-14(12)13(20)8-11;19-12-7-10(6-11-8-20-24-13(11)12)15-14(9-4-2-1-3-5-9)21-16(17(25)22-15)23-18(26)27/h1-3,6-7,10-12,14H,4-5,8-9H2,(H,25,29)(H,27,31)(H,26,28,30);1-5,9-12H,6-8H2,(H,24,28)(H,27,30)(H,25,26,29);3-10H,2H2,1H3,(H,22,26)(H,24,27)(H,23,25,28);2-9H,1H3,(H,21,25)(H,23,26)(H,22,24,27);1-8H,(H,20,24)(H,21,23)(H,22,25)(H,26,27).
What are the key properties of [6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamic acid;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]cyclopentanecarboxamide;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]-2-cyclopropylacetamide;ethyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate;methyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate?
[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamic acid;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]cyclopentanecarboxamide;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]-2-cyclopropylacetamide;ethyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate;methyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate has a molecular weight of 2041.19 g/mol, XLogP of 20.87, 19 rotatable bonds, 16 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for [6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamic acid;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]cyclopentanecarboxamide;N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]-2-cyclopropylacetamide;ethyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate;methyl N-[6-(7-chloro-1H-indazol-5-yl)-2-oxo-5-phenyl-1H-pyrazin-3-yl]carbamate is sourced from PubChem (CID 159991999), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).